HOME EDITORIAL BOARD CONTACT US SUBSCRIPTION AUTHORS INDEX AUTHORS INSTRUCTIONS SUPPLEMENTARY DATA




2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
   
 VOLUME 13 - NUMBER 1
/ January - March 2011

 
Dyslipidemia Related to Antiretroviral Therapy
Vicente Estrada and Joaquín Portilla |Full Article in PDF|
Department of Infectious Diseases, Hospital Clínico San Carlos, Madrid, Spain
 
Abstract

Dyslipidemia is frequently observed in HIV-infected patients. Its pathogenesis is complex and includes factors related to the virus, the host, and antiretroviral treatment. Dyslipidemia is a main cardiovascular risk factor and it is partially modifiable. Whereas HIV infection and its treatment are associated with a state of accelerated atherosclerosis and an increase in the number of cases of myocardial infarction, dyslipidemia management must be a priority in the clinical care of patients with HIV infection. In this review, we discuss the major pathogenic mechanisms of dyslipidemia associated with antiretroviral therapy and the effect of the currently used drugs on the lipid profile. The current recommendations for dyslipidemia management include the control of other cardiovascular risk factors, the choice of antiretroviral drugs with a better lipid profile, and lipid-lowering drug use when clinically indicated.

 
Key words:
Dyslipidemia. HIV infection. Antiretroviral therapy. Cardiovascular risk.
 
Date: 27/09/2016
ISSN: 1698-6997
 
unsubscribe 

LOGIN 
Not a member?
REGISTER 

Editor's access. 



I National Conference of the GEHEP of SEIMC (Abstract book)
PERMANYER PUBLICATIONS
Mallorca, 310
08037 Barcelona - Spain
Phone: +34 93 207 59 20
Fax: +34 93 457 66 42
www.permanyer.com


 
© 2016 Permanyer Publications - Legal notice
Made & Powered by IMMA PUIG
Mallorca, 310 - 08037 Barcelona, Spain. Tel.: +34 93 207 59 20 - Fax: +34 93 457 66 42